Figure 3
Figure 3a Men
|
Adana, Turkey
|
Bergen, Norway
|
Elazig, Turkey
|
Hannover, Germany
|
Krakow, Poland
|
Maastricht, Netherlands
|
Porto, Portugal
|
Reykjavik, Iceland
|
Salzburg, Austria
|
10 cities in Spain
|
Uppsala, Sweden
|
GOLD stage II
|
13.1
|
9.4
|
10.5
|
7.5
|
10.3
|
|
11.6
|
6.7
|
9.3
|
|
|
GOLD stage II - IV
|
|
|
|
|
|
13.2
|
|
|
|
7.1
|
6.8
|
GOLD stage III–IV
|
2.3
|
1.6
|
2.3
|
1.1
|
3.0
|
|
0.7
|
1.9
|
1.0
|
|
|
Figure 3b Women
|
Adana, Turkey
|
Bergen, Norway
|
Elazig, Turkey
|
Hannover, Germany
|
Krakow, Poland
|
Maastricht, Netherlands
|
Porto, Portugal
|
Reykjavik, Iceland
|
Salzburg, Austria
|
10 cities in Spain*
|
Uppsala, Sweden
|
GOLD stage II
|
5.3
|
5.0
|
4.5
|
3.1
|
7.8
|
|
6.5
|
7.4
|
9.2
|
|
|
GOLD stage II-IV
|
|
|
|
|
|
8.0
|
|
|
|
2.0
|
6.6
|
GOLD stage III–IV
|
0.7
|
0.9
|
0.7
|
0.6
|
0.8
|
|
1.1
|
2.0
|
1.8
|
|
|
Figure 3
– Prevalence of chronic obstructive pulmonary disease (COPD) in a) men and b) women aged ≥40 years in European cities, by Global Initiative for Obstructive Lung Disease stage, ranked by national prevalence of current smoking. Data from multiple publications resulting from the Burden of Obstructive Lung Disease (BOLD) study.
Download Raw Data
See the entire Obstructive pulmonary disease Chapter